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Abstract 
 
Sinus Augmentation Using BMP-2 in a Bovine 
Hydroxyapatite/Collagen Carrier in Dogs 
 
Jae Kook Cha, D.D.S., M.S.D. 
 
Department of Dentistry 
The Graduate School, Yonsei University 
(Directed by Professor Seong-Ho Choi, D.D.S., M.S.D., PhD.) 
 
Objective: The objective of this study was to determine the efficacy of bone 
morphogenetic protein 2 (BMP-2) in a bovine hydroxyapatite/collagen (BHC) carrier 
to augment bone formation in a canine nasal sinus model. 
Material and Methods: Eight mongrel dogs, approximately 12 months old and 30 kg 
in weight were used. Following preparation of bilateral sinus access windows, BHC 
alone (control) or loaded with E.coli-derived BMP-2 at 0.1 mg/mL was implanted in 
4 animals, and BHC loaded with E.coli-derived BMP-2 at 0.5 and 1.5 mg/mL was 
implanted in 4 animals. The animals were euthanized at 20 weeks when block 
sections were obtained for micro-computed tomography and histometric analyses. 
Results: Total augmented volumes did not differ significantly between groups. 
v 
 
Histometric analysis showed significantly enhanced bone formation for the BMP-2 
groups compared with control. 
Conclusion: BMP-2 in a BHC carrier, even at the low 0.1-mg/mL concentration, 
induces osteogenic activity, enhancing local bone formation in a canine sinus model. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KEYWORDS: bone substitutes, bone tissue engineering, bone regeneration, sinus 
augmentation
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I. Introduction 
 
A number of studies have demonstrated extensive bone formation using bone 
morphogenetic protein 2 (BMP-2) with different carriers in various animal sinus 
augmentation models (Park, 2009). Among them, BMP-2 in absorbable collagen 
sponge (ACS) carrier was shown to be more effective than autogenous bone grafts 
and have been considered the new gold standard for this indication (Lee et al., 2013). 
Along with the superior effects of BMP-2/ACS in preclinical models, clinical studies 
have demonstrated successful results following the use of BMP-2/ACS for maxillary 
sinus augmentation (Boyne et al., 2005; Triplett et al., 2009). 
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The concentration of BMP-2 to induce the most effective bone formation is still 
unclear and it is influenced by various factors; e.g. delivery system, release kinetics 
and recipient site (Seeherman et al., 2002). In vitro and in vivo studies using strict 
dose analysis have shown an inverse correlation between bone maturation and BMP-2 
dose (Park et al., 2012; Song et al., 2011; Wikesjo et al., 2008; Zara et al., 2011).      
However, in regards to sinus augmentation, the study of BMP-2 concentration matters 
relative to bone formation/maturation, and occurrence/severity of adverse events has 
not yet been reported. A wide range of BMP-2 concentrations have been used in 
preclinical sinus augmentation models (Choi et al., 2012; Gutwald et al., 2010; 
Hanisch et al., 1997; Lee et al., 2013). We should consider that these studies were 
performed in different experimental animals with various carrier systems and also that 
the biologic response varies between recipient sites, thus, the results of these studies 
could not be directly compared. Therefore, a study to determine the effects of BMP-2 
depending on the concentration in sinus model is needed. 
The objective of this study was to determine the efficacy of BMP-2 in a bovine 
hydroxyapatite/collagen (BHC) carrier to augment bone formation in the canine nasal 
sinus model.
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              II. Materials and Methods 
 
1. Experimental Animals 
Eight mongrel dogs aged about 12 months and weighing approximately 30 kg 
were used. All had healthy dentitions and periodontal tissues without any systemic 
disease. The selection and management of experimental animals and surgical 
procedures followed a protocol approved for this study by the Institutional Animal 
Care and Use Committee, College of Medicine, Yonsei University (09-021). 
 
2. Experimental Design 
E. coli derived BMP-2 was provided from the Research and Development 
Institute of Cowellmedi (Busan, Korea). The BMP-2 expressed by E. coli has been 
described in detail previously (Lee et al., 2010). BMP-2 was reconstituted and diluted 
in a buffer to obtain concentrations of 0.1, 0.5, and 1.5 mg/ml, and then 250 mg of 
BHC (Bio-Oss Collagen, Geistlich Pharma AG, Wolhusen, Switzerland) was loaded 
with 200 l of one of the three different concentrations of BMP-2 or saline (control). 
The BHC blocks were a uniform volume of 9 x 9 x 8 mm in width, length and height. 
BMP-2 was loaded using an auto pipette in a sterilized culture dish, and after 
allowing 10 min for the BMP-2 to adsorb onto the surface of BHC, the blocks were 
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placed into the nasal sinuses. The experimental sites were divided into four groups 
according to the dose of BMP-2 applied (n = 4 per group): 
i) Control group: BHC loaded with normal saline. 
ii) BHC loaded with BMP-2 at 0.1 mg/ml (total dose = 0.02 mg). 
iii) BHC loaded with BMP-2 at 0.5 mg/ml (total dose = 0.10 mg). 
iv) BHC loaded with BMP-2 at 1.5 mg/ml (total dose = 0.30 mg). 
Control and 0.1 mg/ml BMP-2 group were assigned in each sinus of four dogs, 
0.5 and 1.5mg/ml BMP-2 groups were assigned in the other four dogs. 
 
3. Surgical Procedure 
 The maxillary premolars were extracted bilaterally prior to the experimental 
surgery and the experimental sites were allowed to heal for 2 months. The 
experimental surgical procedure was performed under general anesthesia. The 
anesthetic procedure was described in our previous report (Oh et al., 2011). 
After healing following extraction, the edentulous region was accessed using 
buccal incisions. A horizontal incision was made at the gingival crest from the first 
premolar to the third premolar, from which a vertical incision was extended apically. 
The full-thickness flap was elevated and the lateral bone wall was removed using an 
8-mm-diameter trephine bur under sufficient saline irrigation. The position of the 
lateral window was determined using intraoral radiographs of the edentulous area. 
The membrane was carefully elevated from the floor (Fig. 1a) and lateral walls, and 
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then the BMP-2-loaded scaffold was applied to the created space (Fig. 1b and c). The 
flap was repositioned using a suture material (4-0 Monosyn; glyconate absorbable 
monofilament, B-Braun, Aesculap, Center Valley, PA, USA). The animals were 
euthanized by anesthetic drug overdose at 20 weeks. 
 
4. Radiographic Analysis 
Block sections that included BHC were dissected and fixed in 10% neutral 
buffered formalin for 10 days (Fig. 1d). The fixed specimens were scanned in a micro 
computed tomography (micro-CT; SkyScan 1072, SkyScan, Aartselaar, Belgium) at a 
resolution of 35 μm (100 kV, 100 μA). The scanned data were saved in DICOM 
format, and the experimental area was reconstructed with OnDemand 3D software 
(CyberMed, Seoul, Korea). In all sectioned planes, the total augmented areas were 
identified by color coding and traced manually by one experienced examiner using 
the software program. The composition of the augmented area were automatically 
indicated according to the gray values of the threshold, and then modified manually 
for fine distinction between bovine hydroxyapatite (BH) and new bone (NB) in all 
sectioned planes (Fig. 1e). The gray values of threshold were standardized and they 
ranged from 145 to 225 for BH and from 95 to 145 for NB. The overall dimensional 
topography of experimentally grafted sinus cavities were visualized with the aid of 
three-dimensionally (3D) reconstructed images. The total augmented volume and 
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volume of BH (mm3) were calculated by integration of the data from all tomographic 
images. 
 
5. Histologic Analysis 
After rinsing the specimens in sterile water, the sections were decalcified in 5% 
formic acid, dehydrated in a graded ethanol series, and embedded in paraffin. Serial 
sections were cut at a thickness of 5 µm in an apicocoronal vertical plane. The two 
most central sections of each grafted site were selected and stained with hematoxylin-
eosin and Masson’s trichrome. Histologic analysis was performed using a 
stereomicroscope (MZFLIII, Leica, Wetzlar, Germany) and light microscope (BX-50, 
Olympus Optical, Tokyo, Japan). 
 
6.  Histomorphometric Analysis 
Micrographs were taken at a magnification of ×12.5 and assembled to enable 
visualization of the entire sinus. After examination with a conventional light 
microscope, histomorphometric measurements were made using a PC-based image-
analysis system (Image-Pro Plus, Media Cybernetics, Silver Spring, MD, USA). The 
histomorphometric analysis was performed by one experienced, masked examiner 
(J.S.L.). To minimize intraexaminer errors, several randomly selected samples were 
measured twice with a 1-week interval. The intraexaminer reproducibility was 
evaluated using the concordance correlation coefficient, which was 0.93-0.98 
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(Barnhart et al., 2007; Lin, 1989). Each photomicrograph was horizontally aligned 
and imaginary horizontal line was established according to the base of nasal sinus 
floor for linear measurement. The following measurements were made as primary 
outcome variables (Fig. 1f): 
i) Total augmented area (mm2) and height (mm): the experimentally augmented 
area surrounded by the floor of nasal sinus and Schneiderian membrane, 
including NB, residual BH particles, and FCT. Augmented height was 
defined as the distance from the floor of the nasal sinus to the highest point of 
the total augmented area. 
ii) NB height proportion (%NBH; %): the proportion of the distance from the 
floor of the nasal sinus to the highest point of NB within the sinus (NBH) in 
relation to the total augmented height. 
iii)  Composition of the augmented area (%): the proportions of NB (%NB), 
residual particles (%BH), and FCT (%FCT) relative to the total augmented 
area. 
 The following additional measurements were made as secondary outcome 
variables, to evaluate the healing around the residual particles and the homogeneity of 
bone regeneration: 
i) Proportions of BH particles surrounded by NB (%BHB): the proportion of 
the number of BH particles surrounded by NB relative to the total number of 
BH particles in the augmented area. 
ii) Separated fractions of NB in the central and peripheral portions of the 
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augmented area (%; Fig. 1f): %NB in selected central and peripheral areas, 
respectively. The central-most vertical and horizontal area, and the 
horizontally central/most-coronal area were selected for this measurement. 
 
7. Statistics 
Group means (±SD) were calculated. Statistical analyses were performed 
separately at the intra- and inter-subject levels. Wilcoxon signed-rank test was used 
for the comparison between control and 0.1 mg/ml BMP-2 group, and 0.5 and 1.5 
mg/ml groups. Mann-Whitney U test used to compare groups which were allocated in 
different animals; control versus 0.5 and 1.5 mg/ml groups, and 0.1 mg/ml group 
versus 0.5 and 1.5 mg/ml groups. The level of statistical significance was set at p < 
0.05.
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                   III. RESULTS 
 
1. Clinical Findings 
Surgical wound healing was uneventful during the experimental period. Nasal 
bleeding occurred immediately after the surgical procedure in several dogs, but it 
stopped within an hour. No complications – including membrane perforation, wound 
dehiscence, severe swelling, and bleeding – were observed. 
 
2. Radiographic Analysis 
The 3D reconstructed images revealed the entire shape of the augmented area 
(Fig. 2). In the control group, the BHC had almost maintained its original rectangular 
block shape over the sinus floor. However, the BH had become spread out and 
flattened on the sinus floor in the BMP-2-treated groups. 
NB and BH could be observed in the cross-sectional images (Fig. 2). In the 
control group, the BH particles were still evident at the floor of the sinus and only a 
small amount of NB was observed inside the BHC. In the BMP-2-treated groups, the 
BH particles appeared to have disassembled and were scattered over the sinus floor. 
With a BMP-2 dose of 0.1 mg/ml, a bone bridge had formed within the BHC block so 
that the BH and the NB had become commingled. In the groups with BMP-2 at 0.5 
and 1.5 mg/ml, the amount of BH was significantly reduced and abundant NB was 
 10 
 
observed, homogeneous with the original sinus floor. The volume of BH in the BMP-
2 treated groups tended to be lower than that in the control group, however the 
differences between groups were not statistically significant on intra/inter subject 
level tests (control group, 26.25 ± 15.01 mm3; 0.1 mg/ml BMP-2 group, 14.50 ± 
10.32 mm3; 0.5 mg/ml BMP-2 group, 12.52 ± 16.42 mm3; 1.5 mg/ml BMP-2 group, 
11.21 ± 5.25 mm3).  Also, the total augmented volumes did not differ statistically 
between the groups (control group, 253.99 ± 41.00 mm3; 0.1 mg/ml BMP-2 group, 
346.61 ± 102.75 mm3; 0.5 mg/ml BMP-2 group, 246.93 ± 95.97 mm3; 1.5 mg/ml 
BMP-2 group, 317.50 ± 95.78 mm3). 
 
3. Histologic Findings  
The nasal sinus cavity was surrounded by respiratory mucosa and a thin layer of 
cortical bone. The Schneiderian membrane was intact, with no sign of inflammation 
in all groups. 
 In the control group, most of the BH particles were encapsulated by dense 
fibroblastic cells with smooth borders in the whole augmented area, and only a small 
amount of NB could be detected in the original sinus floor. In the central portion of 
the augmented area in particular, the NB was barely visible and multinucleated 
osteoclast-like cells were absent (Fig. 3a, b and c). 
In contrast, in the BMP-2 treated groups, a trabecular pattern of NB was observed 
in direct contact along the Schneiderian membrane. NB was also seen at the tented 
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area lateral to the BHC. In the NB induced by BMP-2, concentric layers of bone 
tissue were observed around Haversian canals and well-defined lamellar bone, 
exhibiting characteristics of mature bone. The osteoclast-like cells were absent and 
the osteoclastic activity was not observed around the BH particles with smooth and 
intact borders (Fig. 3d, e and f, Fig. 4). Interestingly, with 0.5 mg/ml BMP-2 the BH 
particles tightly attached to the NB had penetrated the alveolar bone beneath the 
original sinus floor such that the original sinus floor was barely distinguishable from 
the NB (Fig. 4a, b and c); moreover, with 1.5 mg/ml BMP-2, a large amount of 
completely remodeled NB was observed throughout the entire sinus cavity, and the 
BH particles were barely visible (Fig. 4d, e and f). 
 
4. Histometric Analysis 
The composition of the augmented area is summarized in Fig. 5a and Table 1. Both 
the area of NB (mm2) and %NB were significantly larger in all of the BMP-2-treated 
groups than in the untreated control. Furthermore, the bone formation observed with 
BMP-2 was significantly larger than the control group not only in the central portion 
of augmented area close to the basal bone of the sinus, but also in the peripheral 
portion of augmented area near the Schneiderian membrane (Table 2). 
%BHB and %NBH differed significantly between the control and 0.1 mg/ml BMP-
2 group or 0.5 and 1.5 mg/ml BMP-2 groups. The values in the BMP-2-treated groups 
tended to increase with concentration, but the differences between the groups were 
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not statistically significant at all intra/inter subject level tests (Fig. 5b; %NBH: control 
group, 52.3 ± 27.1%; 0.1 mg/ml BMP-2 group , 97.8 ± 4.3%; 0.5 mg/ml BMP-2 
group, 98.8 ± 2.3%; 1.5 mg/ml BMP-2 group, 100%; %BHB: control group, 29.2 ± 
24.3%; 0.1 mg/ml BMP-2 group , 91.4 ± 8.2%; 0.5 mg/ml BMP-2 group, 97.9 ± 
2.6%; 1.5 mg/ml BMP-2 group, 97.7 ± 4.6%). 
 
Table 1. Composition of the Total Augmented Area. (mean ± standard deviation) 
Group NB (mm2) BH (mm2) FCT (mm2) AA (mm2) 
Control 7.04 ± 2 .43 8.29 ± 1.29 17.75 ± 1.49 33.09 ± 3.04 
BMP-2 (0.1 mg/ml) 18.50 ± 1.1* 4.36 ± 0.25* 10.51 ± 2.09* 33.36 ± 3.04 
BMP-2 (0.5 mg/ml) 22.05 ± 1.91* 2.01 ± 1.02*,† 9.88 ± 2.49* 33.94 ± 5.01 
BMP-2 (1.5 mg/ml) 24.26 ± 5.90* 1.52 ± 0.22*,† 10.88 ± 3.09* 36.65 ± 4.18 
NB, newly formed bone; BH, bovine hydroxyapatite; FCT, fibrovascular connective tissue; 
AA, total augmented area; BMP-2, bone morphogenetic protein 2. 
* Significantly different from control group (p < 0.05). 
†Significantly different from BMP-2 at 0.1 mg/ml (p < 0.05). 
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Table 2. Percentage of NB between the peripheral and central area of the sinus cavity. 
(mean ± standard deviation) 
Group Ce (%) Pe (%) 
Control 5.18 ± 0.95 10.03 ± 1.00 
BMP-2 (0.1 mg/ml) 44.30 ± 5.58* 45.11 ± 7.02* 
BMP-2 (0.5 mg/ml) 38.67 ± 13.80* 42.70 ± 5.79* 
BMP-2 (1.5 mg/ml) 42.29 ± 19.63* 44.58 ± 7.99* 
Ce, central-most vertical and horizontal areas of the augmented graft; Pe, 
horizontally central/most-coronal area of the augmented graft. 
* Significantly different from control group (P < 0.05). 
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IV. DISCUSSION 
 
The present study evaluated osteoinductive activities of BMP-2 in BHC using the 
dog nasal sinus experimental model. Osteogenic activity of BMP-2 was observed 
even at the lowest dose (0.1 mg/ml, corresponding to 0.02 mg of BMP-2), and this 
value was 15 times lower than the approved concentration for human use (1.5mg/ml 
with ACS), nevertheless induced twice the amount of bone regeneration compared to 
the control.  
Previous studies have demonstrated that low quality of bone is attributable to the 
formation of adipose tissue when higher concentrations of BMP-2 are applied (Park et 
al., 2012; Song et al., 2011). However, our findings refute this since we obtained 
good-quality bone with limited adipogenic differentiation at all experimental sites 
including the ones with low and high concentrations of BMP-2. Improved bone 
qualities were shown even at the peripheral portion of augmented areas distant from 
osteogenic sources in all experimental sites, while new bone formation was barely 
observed in this area of the control group. This is concurrent with Choi et al. reporting 
that osteoinductive potential of the Schneiderian membrane is activated at the early 
stage of healing with BMP-2 (Choi et al., 2013). Despite the controversy of whether 
the Schneiderian membrane contains the osteogenic source, the authors suggested that 
newly formed bone from the Schneiderian membrane at the peripheral area could 
protect the augmented space from the volume shrinkage by remodeling process.  
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All experimental sites showed comparable formation of newly formed bone, 
regardless of the concentration of BMP-2. This indicates that increased dose of BMP-
2 beyond a certain threshold would not improve bone regeneration in sinus 
augmentation, and the threshold concentration would be smaller than the present 
experimental range of BMP-2 concentration (0.1-1.5 mg/ml in 200 l) in dog nasal 
sinus model. The sinus augmentation model is a contained defect surrounded by the 
sinus floor and the Schneiderian membrane; thus its healing process could be 
accelerated even with the low BMP-2 concentration. And also characteristics of the 
carrying system could have influenced the present result. BMP-2 may not have been 
fully adsorbed onto the surface of BHC during preparation, and the BMP-2 might not 
be biologically available along the concentration gradient. The adsorption and release 
profiles of BMP-2/BHC have not been verified yet, thus this feature should be fully 
investigated in future studies. 
Interestingly, it was observed that local high dose of BMP-2 (0.5mg/ml) induced 
remodeling of the sinus floor and beyond (1.5mg/ml). In the process of new bone 
formation, a previous study has reported that the BMP-2 dose-dependently stimulated 
osteoclastic bone resorption as well as acted as a mediator of the osteoblast-osteoclast 
interaction (Kanatani et al., 1995). The scattered residual biomaterials surrounded by 
newly formed bone in the present results may be a product of this vigorous 
remodeling process enhanced by BMP-2. While the cortical portion of the original 
sinus floor had been resorbed away in the early healing process, BHC would have 
scattered and sequential new bone formation would have occurred around these 
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particles. Even though the collagen matrix in BHC could enhance the clinical 
manageability, it could be suggested that the structural integrity of BHC might be 
insufficient to support the maintenance of space during the healing process by BMP-2. 
In the same vein, the present results demonstrated a tendency of decrease in the 
proportion of remaining BH at sites that received BMP-2; histological analysis 
revealed significant differences, but volumetric analysis on the reconstructed micro 
CT images did not. This could be explained by excessive swelling in the early healing 
phase of experimental sites and increased bone formation by BMP-2, which could 
have migrated the grafted biomaterial to the lateral aspect of the augmented area. BH 
has been considered as a non-resorbable biomaterial in craniofacial fields (Hallman et 
al., 2001; Hallman and Thor, 2008; Schlegel and Donath, 1998). The previous results 
showed that the BH particles remained similar size to the original BH particles even 
in 7- and 10-year biopsy samples (Mordenfeld et al., 2010; Orsini et al., 2007).  
This study incorporated the nasal sinus model of the dog, which is anatomically 
adjacent to the maxillary premolars and has a similar bone structure to the human 
maxillary sinus which contains alveolar bone and the lateral wall (Aerssens et al., 
1998). Histologically, it has similar compositions to the human Schneiderian 
membrane as the dog sinus membrane is comprised of pseudostratified ciliated 
columnar epithelium which is a respiratory epithelium (Lee et al., 2007). Additionally, 
the intraoral surgical approach in the dog nasal sinus model has a high relevance to 
the human clinical procedure (Wetzel et al., 1995). On the other hand, as the dog 
nasal sinus is connected to the nose, it is subjected to more direct transmission of 
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positive respiratory pressure than the human (Haas et al., 1998). Hence the present 
results may conservatively be interpreted for clinical application in human.  
The present study used two separate statistical analyses; dependent test for 
comparing groups within one animal, and independent test for groups between 
animals. It was caused by the limitation in the number of sinuses of one subject 
animal; therefore, these results should be interpreted conservatively. However, the 
present study focused on whether the significantly reduced concentration (0.1mg/ml) 
of BMP-2 could affect bone healing in sinus augmentation, and the results clearly 
demonstrated extensive new bone formation in comparison to the control. These 
results were comparable to that of the conventional concentrations (0.5 and 1.5mg/ml) 
of BMP-2. Therefore, in continuation of the current focus of minimizing the dosage 
of BMP for bone regeneration, the findings of our study indicate the necessity to 
perform further studies with concentrations of BMP-2 lower than 0.1 mg/ml. 
Within the limitations of this study, it can be concluded that BMP-2 in a BHC 
carrier, even at the low 0.1-mg/mL concentration, induces osteogenic activity, 
enhancing local bone formation in the canine sinus model. 
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Figure Legends 
Figure 1. (a) A trephine bur (outer diameter = 8.0 mm) was used to produce a lateral 
wall osteotomy, and the Schneiderian membrane (SM) was lifted with the aid of a 
periosteal elevator. (b) Bovine hydroxyapatite/collagen (BHC) was inserted beneath 
the membrane. (c) Postoperative periapical radiographic image; BHC (arrows). (d) 
Inner surface image of the lateral wall after decalcification in 5% formic acid. (e) 
Coronally sectioned image of the augmented area identified and indicated with color-
coding using the software program. (f) Schematic drawing of the histometric analysis 
(AB, alveolar bone; NB, newly formed bone; BH, bovine hydroxyapatite; FCT, 
fibrovascular connective tissue; AH, total augmented height; NBH, distance from the 
floor of the nasal sinus to the highest point of NB in AH; Ce, central-most vertical and 
horizontal area; Pe, horizontally central/most-coronal area). 
 
Figure 2. Representative 3D reconstructed and coronally sectioned micro-computed 
tomography images of nasal sinuses. (a, b) Control group; (c, d) with 0.1 mg/ml bone 
morphogenetic protein 2 (BMP-2); (e, f) with 0.5 mg/ml BMP-2; (g, h) with 
1.5 mg/ml BMP-2. 
 
Figure 3. Histologic photomicrographs from the control group (a, b and c), and the 
0.1 mg/ml BMP-2-treated group (d, e and f) (stained with Masson’s trichrome). (a) 
Low-magnification image of the entire sinus from the control group (arrows show a 
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small amount of NB from the original sinus floor; scale bar = 1 mm). (b) Highly 
magnified view of the SM (scale bar = 100 m). (c) Highly magnified view of the 
peripheral part of the augmented area (scale bar = 250 m). (d) Low-magnification 
image of entire sinus from the 0.1 mg/ml BMP-2 treated group. A bone bridge was 
formed along the SM in direct contact with it (arrowheads; scale bar = 1 mm). (e, f) 
Highly magnified polarized photomicrographs of the SM, and the central part of the 
augmented area (scale bar = 250 m). 
 
Figure 4. Histologic photomicrographs from the 0.5 mg/ml BMP-2-treated group (a, 
b and c), and the 1.5 mg/ml BMP-2-treated group (d, e and f) (stained with Masson’s 
trichrome). (a) Low-magnification image of the entire sinus from the 0.5mg/ml BMP-
2 treated group (scale bar = 1 mm). (b, c) Highly magnified polarized 
photomicrographs of the SM, and the central part of the augmented area (scale bar = 
250 m). (d) Low-magnification image of the entire sinus from the 1.5 mg/ml BMP-
2-treated group (scale bar = 1 mm). (e) Highly magnified polarized photomicrograph 
of the SM (scale bar = 100 m). (f) Highly magnified polarized photomicrograph of 
the central part of the augmented area (HC, Haversian canal; scale bar = 250 m). 
 
Figure 5. (a) Composition of the total augmented area. (b) Proportion of the number 
of BH particles surrounded by NB (%; asterisks indicate significant difference from 
the control group, p < 0.05). 
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국문요약 
상악동 거상술 시 탈단백우골/콜라겐 전달체를 사용한 제 2
형 골형성 유도 단백질의 농도에 따른 골 형성 
 
< 지도교수 최성호 > 
연세대학교 대학원 치의학과 
차 재 국 
 
목적: 상악동에서 제 2형 골형성 유도 단백질(BMP-2)의 골 형성 효과
는 여러 선행 연구를 통해 증명되었지만, 아직까지 최적의 농도는 정립되
지 않았다. 상악동 거상술은 치과 술식 중 다량의 골이식재가 사용되는 술
식으로, 과량의 BMP-2의 사용에 따른 부작용이 쉽게 발생할 수 있으므로 
골 형성 효과를 유지하며 부작용을 최소화할 수 있는 이상적인 농도를 정
립하는 과정이 필요하다. 따라서 이 연구의 목적은 개 상악동에서 탈단백
우골/콜라겐 (BHC) 전달체를 사용한 BMP-2의 농도에 따른 골 형성 효과
를 평가하여 최적의 농도를 결정하는 것이다. 
재료 및 방법: 8마리의 잡견 양측에서 상악동 거상술을 시행하였다. 4마
리 개의 한쪽 상악동에는 생리식염수를 첨가한 BHC (대조군)를, 그리고 
다른 한쪽 상악동에는 0.1 mg/ml 농도의 BMP-2를 첨가한 BHC를 이식하
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였다. 나머지 4마리의 개의 상악동에는 각각 0.5, 1.5 mg/ml 농도의 
BMP-2를 첨가한 BHC를 이식하였다. 20주의 치유기간 후, 방사선학적 분
석 및 조직 계측학적 분석을 시행하였다. 
결과: 방사선학적 분석 결과 총 증대된 부피는 실험군과 대조군 간 유의
한 차이를 보이지 않았다. 조직계측학적 분석에 따르면 BMP-2를 첨가한 
군들에서 대조군에 비해 유의하게 증가된 신생골의 면적과 높이를 보였다. 
BMP-2의 농도가 증가할수록 신생골의 양은 증가하는 경향을 보였으나, 
통계적으로 유의한 차이는 없었다. 상악동 내 부위에 따른 골 형성 효과를 
분석한 결과 BMP 처치군은 상악동 중앙부와 주변부에서 모두 균일한 골 
형성이 있었지만, 대조군의 상악동 중앙부에서는 신생골이 거의 관찰되지 
않았다. 
결론: 개 상악동에서 모든 BMP-2 처치군은 BHC를 전달체로 사용하여 
대조군에 비해 현저하게 향상된 골 형성 효과를 보였다. 최소 농도인 0.1 
mg/ml의 BMP-2도 고농도 BMP-2에 비해 유의한 차이 없는 골 형성 효
과를 보였다. 따라서 개 상악동에서 BMP-2의 최적의 농도는 0.1 mg/ml 
이하일 것으로 사료되며 이에 대한 추가적인 연구가 필요하다. 
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